Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Represented SPK Acquisition Corp. in its business combination with Varian Biopharmaceuticals, Inc.

Represented SPK Acquisition Corp. in its initial business combination with Varian Biopharmaceuticals, Inc., a private precision oncology company developing novel therapeutics for the treatment of cancer.